PRIOH-1: Trial on Efficacy and Safety of Pritelivir Tablets for Treatment of Acyclovir-resistant Mucocutaneous HSV (Herpes Simplex Virus) Infections in Immunocompromised Subjects (clinicaltrials.gov) - Jul 30, 2025 - P3 | N=153 | Active, not recruiting | Sponsor: AiCuris Anti-infective Cures AG | Recruiting ➔ Active, not recruiting
Enrollment closed • Herpes Simplex • Infectious Disease
|